Pembrolizumab (Keytruda) administered before and after surgery reduced the risk of death by 26% vs placebo in patients with early-stage non–small cell lung cancer (NSCLC), according to 5-year ...
Defining the role of joint replacement in modern orthopedic care.
The International Liaison Committee on Resuscitation conducts continuous reviews of new, peer-reviewed published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback